BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

991 related articles for article (PubMed ID: 29398533)

  • 21. Generalized Safety and Efficacy of Simplified Intravenous Thrombolysis Treatment (SMART) Criteria in Acute Ischemic Stroke: The MULTI SMART Study.
    Sørensen SB; Barazangi N; Chen C; Wong C; Grosvenor D; Rose J; Bedenk A; Morrow M; McDermott D; Hove JD; Tong DC
    J Stroke Cerebrovasc Dis; 2016 May; 25(5):1110-1118. PubMed ID: 26897101
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recombinant Tissue-Type Plasminogen Activator Study of Wake-Up Ischemic Strokes Guided by Rapid MRI.
    Guo C; Bai Q; Zhao Z; Zhang J
    Cerebrovasc Dis; 2019; 48(1-2):85-90. PubMed ID: 31587000
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Risk of Hemorrhagic Transformation After Thrombolysis for Acute Ischemic Stroke in Chinese Versus North Americans: A Comparative Study.
    Xu X; Wang D; Wang F; Norton C; Liu X; Selim M
    J Stroke Cerebrovasc Dis; 2018 Sep; 27(9):2381-2387. PubMed ID: 29778315
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Brain Imaging Signs and Health-Related Quality of Life after Acute Ischemic Stroke: Analysis of ENCHANTED Alteplase Dose Arm.
    Chen X; Delcourt C; Sun L; Zhou Z; Yoshimura S; You S; Malavera A; Torii-Yoshimura T; Carcel C; Arima H; Hackett ML; Robinson T; Song L; Wang X; Lindley RI; Chalmers J; Anderson CS;
    Cerebrovasc Dis; 2020; 49(4):427-436. PubMed ID: 32702699
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Computed Tomography--Verified Leukoaraiosis Is a Risk Factor for Post-thrombolytic Hemorrhage.
    Willer L; Havsteen I; Ovesen C; Christensen AF; Christensen H
    J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1126-30. PubMed ID: 25920756
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and Efficacy of Intravenous Low-Dose Alteplase in Relative Contraindication Patients with Acute Ischemic Stroke.
    Ohta T; Okada K; Fukuda M; Masahira N; Matsuoka T; Tsuno T; Takemura M
    J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):1844-1851. PubMed ID: 29555402
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predictors of in-hospital mortality and the risk of symptomatic intracerebral hemorrhage after thrombolytic therapy with recombinant tissue plasminogen activator in acute ischemic stroke.
    Al-Khaled M; Matthis C; Eggers J
    J Stroke Cerebrovasc Dis; 2014 Jan; 23(1):7-11. PubMed ID: 22578915
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A model to prevent fibrinolysis in patients with stroke mimics.
    Chang J; Teleb M; Yang JP; Alderazi YJ; Chapple K; Frey JL; Restrepo L
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):839-43. PubMed ID: 21640609
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fixed Dose IV rt-PA and Clinical Outcome in Ischemic Stroke Patients With Body Weight >100 kg: Pooled Data From 3 Randomized Clinical Trials.
    Majidi S; Leon Guerrero CR; Burger KM; Sigounas D; Olan WJ; Qureshi AI
    J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2843-2848. PubMed ID: 30076113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravenous tissue plasminogen activator for patients with minor ischemic stroke.
    Huisa BN; Raman R; Neil W; Ernstrom K; Hemmen TM
    J Stroke Cerebrovasc Dis; 2012 Nov; 21(8):732-6. PubMed ID: 21531576
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thrombolysis for acute ischemic stroke: do patients treated out of hours have a worse outcome?
    Fang K; Churilov L; Weir L; Dong Q; Davis S; Yan B
    J Stroke Cerebrovasc Dis; 2014 Mar; 23(3):427-32. PubMed ID: 23635920
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical Predictors of Stroke Mimics in Patients Treated with Recombinant Tissue Plasminogen Activator according to a Normal Multimodal Computed Tomography Imaging.
    Olindo S; Chardonnet M; Renou P; Coignion C; Debruxelles S; Poli M; Sagnier S; Rouanet F; Sibon I
    J Stroke Cerebrovasc Dis; 2018 Feb; 27(2):454-459. PubMed ID: 29128327
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thrombolysis in dementia patients with acute stroke: is it justified?
    Paciaroni M; Pantoni L
    Neurol Sci; 2017 Jan; 38(1):27-31. PubMed ID: 27699498
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multicenter Study of Intravenous Recombinant Tissue Plasminogen Activator Infusion around Hiroshima, Japan: The Hiroshima Acute Stroke Retrospective and Prospective Registry Study.
    Aoki S; Hosomi N; Sueda Y; Kono T; Takamatsu K; Ohyama H; Torii T; Kitamura T; Nomura E; Noda K; Ohtsuki T; Matsumoto M;
    J Stroke Cerebrovasc Dis; 2015 Dec; 24(12):2747-53. PubMed ID: 26360972
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does Prior Antiplatelet Treatment Increase the Risk of Hemorrhagic Transformation and Unfavorable Outcome on Day 90 after Intravenous Thrombolysis in Acute Ischemic Stroke Patients?
    Chen S; Lu X; Zhang W; Han Z; Yang W; Huang X; Jin X; Wang Z; Liang H; Qiu W; Cheng J; Shao B
    J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1366-70. PubMed ID: 26996750
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Intravenous Thrombolysis and Passes of Thrombectomy as Predictors for Endovascular Revascularization in Ischemic Stroke.
    Angermaier A; Michel P; Khaw AV; Kirsch M; Kessler C; Langner S
    J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2488-95. PubMed ID: 27495833
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early neurological deterioration within 24 hours after intravenous rt-PA therapy for stroke patients: the Stroke Acute Management with Urgent Risk Factor Assessment and Improvement rt-PA Registry.
    Mori M; Naganuma M; Okada Y; Hasegawa Y; Shiokawa Y; Nakagawara J; Furui E; Kimura K; Yamagami H; Kario K; Okuda S; Koga M; Minematsu K; Toyoda K
    Cerebrovasc Dis; 2012; 34(2):140-6. PubMed ID: 22854333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiple cerebral microbleeds in hyperacute ischemic stroke: impact on prevalence and severity of early hemorrhagic transformation after thrombolytic treatment.
    Kim HS; Lee DH; Ryu CW; Lee JH; Choi CG; Kim SJ; Suh DC
    AJR Am J Roentgenol; 2006 May; 186(5):1443-9. PubMed ID: 16632743
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
    Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
    Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors of hemorrhagic transformation after intravenous thrombolysis with rt-PA in acute cerebral infarction.
    Wang R; Zeng J; Wang F; Zhuang X; Chen X; Miao J
    QJM; 2019 May; 112(5):323-326. PubMed ID: 30566606
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 50.